These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 757420)

  • 1. [Effect of Dantrium on spasticity in paraplegic and tetraplegic patients (author's transl)].
    van Laere M; Leus P; Mastelinck C
    J Belge Med Phys Rehabil; 1978; 1(2):189-99. PubMed ID: 757420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of spasticity in paraplegia. A new muscle relaxant Ciba 34'647-Ba].
    Henning K; Edelmann P
    Med Welt; 1972 Feb; 23(6):203-5. PubMed ID: 5060489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dantrolene in juvenile spasticity: 3 months of daily observation].
    Berruti P
    Riv Neurol; 1979; 49(1):30-52. PubMed ID: 451397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)].
    Gonsette RE; Capart T; Demonty L
    Acta Neurol Belg; 1978; 78(3):141-7. PubMed ID: 352084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurophysiologic mechanisms of hemiplegic and paraplegic spasticity: implications for therapy.
    Herman R; Freedman W; Mayer N
    Arch Phys Med Rehabil; 1974 Aug; 55(8):338-43. PubMed ID: 4368954
    [No Abstract]   [Full Text] [Related]  

  • 7. Dantrolene sodium for treatment of spasticity.
    Med Lett Drugs Ther; 1974 Jul; 16(15):61-2. PubMed ID: 4843632
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium).
    Dykes MH
    JAMA; 1975 Feb; 231(8):862-4. PubMed ID: 1089167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dantrolene sodium on spasticity in multiple sclerosis.
    Gelenberg AJ; Poskanzer DC
    Neurology; 1973 Dec; 23(12):1313-5. PubMed ID: 4796610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].
    Ladd HW; Gingras G; Boucher J; Kazdan N; Keenan R
    Union Med Can; 1973 May; 102(5):1087-92. PubMed ID: 4576244
    [No Abstract]   [Full Text] [Related]  

  • 11. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of cerebral palsy: subjectivity and a conundrum.
    Bodensteiner JB
    J Child Neurol; 1996 Mar; 11(2):75-76. PubMed ID: 8881980
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Dantrium on spasticity in multiple sclerosis.
    Ladd H; Oist C; Jonsson B
    Acta Neurol Scand; 1974; 50(4):397-408. PubMed ID: 4277694
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of a new myorelaxant in neurological affections (author's transl)].
    Chantraine A; Van Ouwenaller C
    J Belge Med Phys Rehabil; 1981; 4(1):5-14. PubMed ID: 7309686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sodium dantrolene (dantrium) in the treatment of neurogenic muscular spasm].
    Couto B; Figuereido HB; Araújo Leitão RE; Alvarenga H; Gomes Marleide M; Melo Reis CH
    Neurol Neurocir Psiquiatr; 1976; 17(4):213-21. PubMed ID: 1018726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.
    Felz MW; Haviland-Foley DJ
    South Med J; 2001 May; 94(5):502-4. PubMed ID: 11372801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziconotide for the treatment of severe spasticity after spinal cord injury.
    Ridgeway B; Wallace M; Gerayli A
    Pain; 2000 Mar; 85(1-2):287-9. PubMed ID: 10692630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of spasticity in neurological disease by dantrolen-sodium (author's transl)].
    Chantraine A; van Ouwenaller C
    Nervenarzt; 1980 Jan; 51(1):50-4. PubMed ID: 7393365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.